NCT00058994View on ClinicalTrials.gov

An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2003

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Macular DegenerationMaculopathy, Age-Related
Interventions
DRUG

anecortave acetate

Trial Locations (1)

Unknown

South America, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY